Subjective Well Being of Schizophrenic Patients in Greece
Completed
- Conditions
- Schizophrenia
- Registration Number
- NCT00857064
- Lead Sponsor
- AstraZeneca
- Brief Summary
Non-interventional study aiming to provide data on the subjective effects of antipsychotic medication assessing subjective well-being and global functioning of patients with Schizophrenia under antipsychotic medication. Moreover it aims to assess their adherence to the treatment and will investigate whether there is any correlation of these factors with the clinical condition of these patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
- Provision of written informed consent
- Diagnosis of schizophrenia according to DSM-IV
- The patient must have been prescribed an atypical antipsychotic for at least 4 weeks before the first study visit
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of Subjective well being Relative score reported in SWBN scale at the visit. No baseline comparison Assessment of functioning Relative score reported in GAF scale at the visit. No baseline comparison
- Secondary Outcome Measures
Name Time Method Assessment of Compliance to therapy Relative score reported in BARS scale at the visit. No baseline comparison Assessment of General Psychopathology Relative score reported in PANNS scale at the visit. No baseline comparison Assessment of Clinical Condition Relative score reported in CGIS scale at the visit. No baseline comparison
Trial Locations
- Locations (1)
Research Site
🇬🇷Volos, Greece